Medical Grand Rounds

Provided by University of Connecticut School of Medicine Office of Community and Continuing Medical Education and the Department of Medicine.

Speaker: Daniel Morganstern, MD, Assistant Professor, Hematology-Oncology, UConn Health
Title: Breast Cancer in the 21st Century- What we've Abandoned, What we've Embraced
Date: Thursday, October 8, 2026
Time: 8:00-9:00 am
Location: Keller Auditorium
 
Session Attendance Code: YABWOV
 
Session Learning Objectives:  Participants will (be able to):
1.  Accurately attribute the relative contributions of screening and therapeutic advanced to the declining mortality seen in breast cancer amongst all age groups
2.  Demonstrate a working knowledge of the modern taxonomy of Breast cancer subtypes
3.  Distinguish higher risk breast cancer presentations from lower risk presentations based on the taxonomy, advances in risk stratification and available therapeutics that have improved outcomes.

4.  Estimate prognosis of metastatic breast cancer more accurately based on taxonomy and significant advances in all most subtypes of breast cancer                                  

 

Speaker Disclosure Statement: Daniel Morganstern, MD for this educational event, has a financial relationship with Novartis that could be perceived as a real or apparent conflict of interest in the context of their role as the speaker. The following mitigated safeguard(s) have been put into place: The activity director peer-reviewed the content of the speaker’s presentation ensure that no commercial bias exists. All the relevant financial relationships listed for this individual have been mitigated.
 
 
Speaker Off-label Statement: Daniel Morganstern, MD will be discussing an off-labeled, or investigational use of Olaparib, Carboplatin, Durvalumab Trastuzumab Deruxtecan, trastuzumab Pertuzumab, Giradestrant palbociclb, ribociclib, abemaciclib letrozole anastrozole and exemestance, each in the context of clinical trials performed. Some of these agents are approved for other breast cancer indications, and some have been submitted and are awaiting FDA approval.
Speaker AI Statement: Daniel Morganstern, MD has not used AI tools in the preparation of this session.
 

Target Audience: Practicing physicians, medical residents and fellows, medical students, and other healthcare professionals such as nurses, physician assistants (PAs), and advanced practice registered nurses (APRNs).

Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Connecticut School of Medicine designates this live activity for a maximum of _ 1 _ AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to _ 1 _ MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

Activity Director & Planning Committee Disclosure Statement:  Neither the activity director, the activity administrator, nor the planning committee members in their role as planning committee members for this educational event, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. There are no relevant financial relationships listed for this individual to be mitigated.

Commercial Support Statement: This CME activity has no commercial support associated with it.

Session date: 
10/08/2026 - 8:00am to 9:00am EDT
Location: 
UConn Health
263 Farmington Ave
Keller Auditorium
Farmington, CT 06030
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ABIM Medical Knowledge
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or register to take this course.
Faculty List: 
Speaker(s)

Daniel Morganstern, MD

has no relevant financial relationships to disclose at this time.